Cetuximab plus chemotherapy in patiens with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064211%3A_____%2F09%3A%230000056" target="_blank" >RIV/00064211:_____/09:#0000056 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Cetuximab plus chemotherapy in patiens with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
Original language description
his randomized phase III trial investigated the efficacy and safety of cetuximab plus chemotherapy in patiens with advanced non-small-cell lung cancer (FLEX) in first line treatment. Adding cetuximab to chemotherapy prolongs survival
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FC - Pneumology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
The Lancet
ISSN
0140-6736
e-ISSN
—
Volume of the periodical
373
Issue of the periodical within the volume
9774
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
—
UT code for WoS article
000265710300031
EID of the result in the Scopus database
—